Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease. / Jensen, Magnus T; Marott, Jacob Louis; Lange, Peter; Vestbo, Jørgen; Schnohr, Peter; Nielsen, Olav Wendelboe; Jensen, Jan Skov; Jensen, Gorm Boje.

I: The European Respiratory Journal, Bind 42, Nr. 2, 08.11.2012, s. 341-349.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, MT, Marott, JL, Lange, P, Vestbo, J, Schnohr, P, Nielsen, OW, Jensen, JS & Jensen, GB 2012, 'Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease', The European Respiratory Journal, bind 42, nr. 2, s. 341-349. https://doi.org/10.1183/09031936.00072212

APA

Jensen, M. T., Marott, J. L., Lange, P., Vestbo, J., Schnohr, P., Nielsen, O. W., Jensen, J. S., & Jensen, G. B. (2012). Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease. The European Respiratory Journal, 42(2), 341-349. https://doi.org/10.1183/09031936.00072212

Vancouver

Jensen MT, Marott JL, Lange P, Vestbo J, Schnohr P, Nielsen OW o.a. Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease. The European Respiratory Journal. 2012 nov. 8;42(2):341-349. https://doi.org/10.1183/09031936.00072212

Author

Jensen, Magnus T ; Marott, Jacob Louis ; Lange, Peter ; Vestbo, Jørgen ; Schnohr, Peter ; Nielsen, Olav Wendelboe ; Jensen, Jan Skov ; Jensen, Gorm Boje. / Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease. I: The European Respiratory Journal. 2012 ; Bind 42, Nr. 2. s. 341-349.

Bibtex

@article{caa33cb87b1d45c9af96af6b30db2dca,
title = "Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease",
abstract = "The clinical significance of high heart rate in COPD is unexplored.We investigated the association between resting heart rate (RHR), pulmonary function, and prognosis in subjects with COPD.16,696 subjects above 40 years from The Copenhagen City Heart Study, a prospective study of the general population, followed for 35.3 years, 10,986 deaths occurring. Analyses were performed using time-dependent Cox-models and net reclassification index (NRI).RHR increased with severity of COPD (p<0.001). RHR was associated with both cardiovascular and all-cause mortality across all stages of COPD (p<0.001).Within each stage of COPD, RHR improved the prediction of median life expectancy; the difference between <65 bpm and >85 bpm was 5.5 years in no COPD, 9.8 years in mild, 6.7 years in moderate, and 5.9 years in severe/very severe, (p<0.001). RHR significantly improved risk prediction when added to GOLD stage, (categorical NRI 4.9%, p=0.01; categoryless NRI 23.0%, p<0.0001), or FEV1 in percent of predicted (categorical NRI 7.8%, p=0.002; categoryless NRI 24.1%, p<0.0001).RHR increases with severity of COPD. RHR is a readily available clinical variable that improves risk prediction in patients with COPD above and beyond that of pulmonary function alone. RHR may be a potential target for intervention in COPD.",
author = "Jensen, {Magnus T} and Marott, {Jacob Louis} and Peter Lange and J{\o}rgen Vestbo and Peter Schnohr and Nielsen, {Olav Wendelboe} and Jensen, {Jan Skov} and Jensen, {Gorm Boje}",
year = "2012",
month = nov,
day = "8",
doi = "10.1183/09031936.00072212",
language = "English",
volume = "42",
pages = "341--349",
journal = "The European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "2",

}

RIS

TY - JOUR

T1 - Resting Heart Rate is a Predictor of Mortality in Chronic Obstructive Pulmonary Disease

AU - Jensen, Magnus T

AU - Marott, Jacob Louis

AU - Lange, Peter

AU - Vestbo, Jørgen

AU - Schnohr, Peter

AU - Nielsen, Olav Wendelboe

AU - Jensen, Jan Skov

AU - Jensen, Gorm Boje

PY - 2012/11/8

Y1 - 2012/11/8

N2 - The clinical significance of high heart rate in COPD is unexplored.We investigated the association between resting heart rate (RHR), pulmonary function, and prognosis in subjects with COPD.16,696 subjects above 40 years from The Copenhagen City Heart Study, a prospective study of the general population, followed for 35.3 years, 10,986 deaths occurring. Analyses were performed using time-dependent Cox-models and net reclassification index (NRI).RHR increased with severity of COPD (p<0.001). RHR was associated with both cardiovascular and all-cause mortality across all stages of COPD (p<0.001).Within each stage of COPD, RHR improved the prediction of median life expectancy; the difference between <65 bpm and >85 bpm was 5.5 years in no COPD, 9.8 years in mild, 6.7 years in moderate, and 5.9 years in severe/very severe, (p<0.001). RHR significantly improved risk prediction when added to GOLD stage, (categorical NRI 4.9%, p=0.01; categoryless NRI 23.0%, p<0.0001), or FEV1 in percent of predicted (categorical NRI 7.8%, p=0.002; categoryless NRI 24.1%, p<0.0001).RHR increases with severity of COPD. RHR is a readily available clinical variable that improves risk prediction in patients with COPD above and beyond that of pulmonary function alone. RHR may be a potential target for intervention in COPD.

AB - The clinical significance of high heart rate in COPD is unexplored.We investigated the association between resting heart rate (RHR), pulmonary function, and prognosis in subjects with COPD.16,696 subjects above 40 years from The Copenhagen City Heart Study, a prospective study of the general population, followed for 35.3 years, 10,986 deaths occurring. Analyses were performed using time-dependent Cox-models and net reclassification index (NRI).RHR increased with severity of COPD (p<0.001). RHR was associated with both cardiovascular and all-cause mortality across all stages of COPD (p<0.001).Within each stage of COPD, RHR improved the prediction of median life expectancy; the difference between <65 bpm and >85 bpm was 5.5 years in no COPD, 9.8 years in mild, 6.7 years in moderate, and 5.9 years in severe/very severe, (p<0.001). RHR significantly improved risk prediction when added to GOLD stage, (categorical NRI 4.9%, p=0.01; categoryless NRI 23.0%, p<0.0001), or FEV1 in percent of predicted (categorical NRI 7.8%, p=0.002; categoryless NRI 24.1%, p<0.0001).RHR increases with severity of COPD. RHR is a readily available clinical variable that improves risk prediction in patients with COPD above and beyond that of pulmonary function alone. RHR may be a potential target for intervention in COPD.

U2 - 10.1183/09031936.00072212

DO - 10.1183/09031936.00072212

M3 - Journal article

VL - 42

SP - 341

EP - 349

JO - The European Respiratory Journal

JF - The European Respiratory Journal

SN - 0903-1936

IS - 2

ER -

ID: 44325708